Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for NMAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 26.65M
March 31, 2026 10.87M
December 31, 2025 12.73M
September 30, 2025 5.434M
June 30, 2025 1.189M
March 31, 2025 1.514M
December 31, 2024 1.146M
September 30, 2024 1.696M
June 30, 2024 2.668M
March 31, 2024 3.589M
December 31, 2023 4.309M
September 30, 2023 5.235M
June 30, 2023 3.095M
March 31, 2023 4.331M
December 31, 2022 5.561M
September 30, 2022 6.820M
June 30, 2022 8.024M
March 31, 2022 4.118M
December 31, 2021 5.093M
September 30, 2021 6.334M
June 30, 2021 7.243M
March 31, 2021 7.890M
December 31, 2020 5.228M
September 30, 2020 1.362M
June 30, 2020 1.892M
Date Value
March 31, 2020 2.276M
December 31, 2019 2.672M
September 30, 2019 3.066M
June 30, 2019 3.619M
March 31, 2019 3.955M
December 31, 2018 4.337M
September 30, 2018 0.4449M
June 30, 2018 0.5828M
March 31, 2018 0.8546M
December 31, 2017 1.368M
September 30, 2017 1.651M
June 30, 2017 2.065M
March 31, 2017 0.9206M
December 31, 2016 0.4334M
September 30, 2016 0.9336M
June 30, 2016 1.379M
March 31, 2016 1.808M
December 31, 2015 0.598M
September 30, 2015 1.027M
June 30, 2015 1.525M
March 31, 2015 1.682M
December 31, 2014 0.5393M
September 30, 2014 0.9962M
June 30, 2014 1.302M
March 31, 2014 0.1879M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics